SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-16-107334
Filing Date
2016-06-07
Accepted
2016-06-07 17:25:27
Documents
6
Period of Report
2016-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A v441869_pre14a.htm PRE 14A 1055447
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_intercept-new.jpg GRAPHIC 34913
4 GRAPHIC sig_mpruzanski.jpg GRAPHIC 14498
5 GRAPHIC sig_bryan-yoon.jpg GRAPHIC 28030
6 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-16-107334.txt   1163727
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35668 | Film No.: 161702114
SIC: 2834 Pharmaceutical Preparations